Overview

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants

Status:
Completed
Trial end date:
2017-11-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of BMS-986263 in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Diphenhydramine
Famotidine
Promethazine